300753SZSE

Aipeng Medical Co., Ltd.

爱朋医疗

300753

Shenzhen Stock Exchange

Follow
37 announcements tracked· Last: May 21, 2026

Key Financials

As of 2026-05-23T00:00:00.000+00:00
Revenue¥68.3M
Net Profit-¥4.4M
ROE-0.66%
Debt Ratio17.29%
Monetary Funds¥96.5M
Receivables¥132.8M
Goodwill¥68.7M
Total Shares126.0M

Announcements

37 total

Announcement on Completion of Business Registration Change and Issuance of New Business License

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Pre-disclosure of Senior Management Share Reduction

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement of Voluntary Information Disclosure on Shareholder Return Activities

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Legal Opinion from Shanghai Junlan Law Firm on the 2025 Annual Shareholders' Meeting of Jiangsu Aipeng Medical Technology Co., Ltd.

Share PledgeShareholding Change DisclosureCapital Reduction

Announcement of Resolutions of the 2025 Annual Shareholders' Meeting

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on holding the 2025 annual and first quarter online performance briefing

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Guangfa Securities Co., Ltd. on the special verification opinion of Jiangsu Aipeng Medical Technology Co., Ltd.'s 2025 annual fundraising fund storage and usage situation

Share PledgeShareholding Change DisclosureCapital Reduction

Announcement on the reappointment of the audit institution for the 2026 fiscal year

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Board of Directors Work Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Audit Committee's review opinion on the company's internal control self-evaluation report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Financial Settlement Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on confirming the compensation plan for directors and senior management for the 2025 and 2026 fiscal years

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Independent Director Work Report (Hou Liyang)

Convertible BondsShareholding Change DisclosureCapital Reduction

2025 Annual Independent Director Work Report (Kong Xiangyong)

Convertible BondsShareholding Change DisclosureCapital Reduction

2025 Annual Independent Director Work Report (Tao Hongxun)

Convertible BondsShareholding Change DisclosureCapital Reduction

2025 Annual Internal Control Audit Report

Share PledgeShareholding Change DisclosureCapital Reduction

2025 Annual Internal Control Self-evaluation Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Articles of Association (April 2026)

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Compensation management system for directors and senior management (April 2026)

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on changing the business scope and revising the Articles of Association

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on changes in accounting policies

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Notice on convening the 2025 Annual Shareholders' Meeting

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement of the resolution of the fourth meeting of the fourth Board of Directors

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the profit distribution plan for the 2025 fiscal year

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2026 First Quarter Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special report on the storage and usage of raised funds for the 2025 fiscal year

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Verification report on the annual storage, management and usage of raised funds

Share Repurchase CompletionShare PledgeShareholding Change Disclosure

Special verification opinion on the deduction of operating income

Share PledgeShareholding Change DisclosureCapital Reduction

Report of the Board of Directors' Audit Committee on the evaluation of the performance of the accounting firm for the 2025 fiscal year and the fulfillment of supervisory responsibilities

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special audit explanation on non-operating fund occupation and other related fund transactions

Share Repurchase CompletionShare PledgeShareholding Change Disclosure

2025 Annual Non-operating Fund Occupation and Other Related Fund Transactions Table

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Board of Directors' special opinion on the independence of independent directors

Share Repurchase CompletionConvertible BondsShareholding Change Disclosure

2025 Annual Audit Report

Share PledgeShareholding Change DisclosureCapital Reduction

2025 Annual Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Report Summary

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on requesting the shareholders' meeting to authorize the board of directors to issue stocks to specific objects through simplified procedures and handle related matters

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Expiration of the Share Reduction Plan and Implementation Status of Shareholders Holding 5% or More of Shares

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Notes & Comments

Sign in to leave a comment or private note.

Loading…